Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of p38MAPK cascade (GO:1900745) | 3.87109622 |
2 | regulation of p38MAPK cascade (GO:1900744) | 3.61521361 |
3 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.29961187 |
4 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 3.09957923 |
5 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 3.09957923 |
6 | cellular response to epinephrine stimulus (GO:0071872) | 3.06442501 |
7 | regulation of cholesterol homeostasis (GO:2000188) | 2.92582278 |
8 | cerebellar granule cell differentiation (GO:0021707) | 2.87442472 |
9 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.87318674 |
10 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.87318674 |
11 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.81147005 |
12 | locomotory exploration behavior (GO:0035641) | 2.79398096 |
13 | positive regulation of histone deacetylation (GO:0031065) | 2.66050851 |
14 | mannose metabolic process (GO:0006013) | 2.65015175 |
15 | detection of molecule of bacterial origin (GO:0032490) | 2.63596459 |
16 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.61786665 |
17 | cellular potassium ion homeostasis (GO:0030007) | 2.61469761 |
18 | growth hormone receptor signaling pathway (GO:0060396) | 2.60859845 |
19 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.59005816 |
20 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.58401729 |
21 | protein targeting to Golgi (GO:0000042) | 2.57897090 |
22 | response to muramyl dipeptide (GO:0032495) | 2.57253849 |
23 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.55931051 |
24 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.55567121 |
25 | response to epinephrine (GO:0071871) | 2.53958465 |
26 | synaptic vesicle maturation (GO:0016188) | 2.53348659 |
27 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.52313816 |
28 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.52313816 |
29 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.52313816 |
30 | negative regulation of interleukin-8 production (GO:0032717) | 2.51339822 |
31 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.49197588 |
32 | response to lipoprotein particle (GO:0055094) | 2.48218687 |
33 | cellular extravasation (GO:0045123) | 2.43425483 |
34 | establishment of protein localization to Golgi (GO:0072600) | 2.42623076 |
35 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.42107770 |
36 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.41220281 |
37 | regulation of ARF protein signal transduction (GO:0032012) | 2.40618680 |
38 | cellular response to catecholamine stimulus (GO:0071870) | 2.39567891 |
39 | cellular response to monoamine stimulus (GO:0071868) | 2.39567891 |
40 | sexual reproduction (GO:0019953) | 2.38009171 |
41 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.32676899 |
42 | coronary vasculature morphogenesis (GO:0060977) | 2.30535932 |
43 | response to monoamine (GO:0071867) | 2.27760740 |
44 | response to catecholamine (GO:0071869) | 2.27760740 |
45 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.26205022 |
46 | suckling behavior (GO:0001967) | 2.25314405 |
47 | response to peptidoglycan (GO:0032494) | 2.24320270 |
48 | negative regulation of inclusion body assembly (GO:0090084) | 2.23404225 |
49 | potassium ion import (GO:0010107) | 2.23260940 |
50 | positive regulation of mRNA catabolic process (GO:0061014) | 2.23204831 |
51 | regulation of mRNA catabolic process (GO:0061013) | 2.22774779 |
52 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.21356264 |
53 | response to corticosterone (GO:0051412) | 2.21328811 |
54 | glutamate receptor signaling pathway (GO:0007215) | 2.20782959 |
55 | nerve growth factor signaling pathway (GO:0038180) | 2.20550655 |
56 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.19003829 |
57 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.17676017 |
58 | response to dietary excess (GO:0002021) | 2.15827170 |
59 | cellular response to growth hormone stimulus (GO:0071378) | 2.15234362 |
60 | proline transport (GO:0015824) | 2.15106781 |
61 | cAMP catabolic process (GO:0006198) | 2.14573440 |
62 | synaptic vesicle exocytosis (GO:0016079) | 2.13664968 |
63 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.13504041 |
64 | protein localization to endosome (GO:0036010) | 2.12402931 |
65 | glycine transport (GO:0015816) | 2.11726638 |
66 | cell-cell junction maintenance (GO:0045217) | 2.08655622 |
67 | response to mineralocorticoid (GO:0051385) | 2.08356894 |
68 | myelin maintenance (GO:0043217) | 2.07364622 |
69 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.05885055 |
70 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.05227840 |
71 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.04454906 |
72 | cell differentiation in hindbrain (GO:0021533) | 2.04082001 |
73 | entrainment of circadian clock by photoperiod (GO:0043153) | 2.04045810 |
74 | cyclic nucleotide catabolic process (GO:0009214) | 2.03708765 |
75 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.03155605 |
76 | negative regulation of glial cell proliferation (GO:0060253) | 2.02745073 |
77 | activation of protein kinase A activity (GO:0034199) | 2.02199517 |
78 | macroautophagy (GO:0016236) | 2.01317799 |
79 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.01282079 |
80 | dendrite morphogenesis (GO:0048813) | 2.00988033 |
81 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.00212954 |
82 | regulation of cardioblast proliferation (GO:0003264) | 2.00030183 |
83 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.00030183 |
84 | histone H3-K4 trimethylation (GO:0080182) | 1.99980436 |
85 | astrocyte differentiation (GO:0048708) | 1.99945449 |
86 | response to fluid shear stress (GO:0034405) | 1.99644419 |
87 | positive regulation of cellular amide metabolic process (GO:0034250) | 1.99557013 |
88 | cell migration in hindbrain (GO:0021535) | 1.98540943 |
89 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 1.98169878 |
90 | neutrophil mediated immunity (GO:0002446) | 1.96719760 |
91 | layer formation in cerebral cortex (GO:0021819) | 1.95149452 |
92 | regulation of triglyceride biosynthetic process (GO:0010866) | 1.94645385 |
93 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 1.94418478 |
94 | ovulation cycle (GO:0042698) | 1.93882460 |
95 | negative regulation of gluconeogenesis (GO:0045721) | 1.93478249 |
96 | white fat cell differentiation (GO:0050872) | 1.93374600 |
97 | neuronal ion channel clustering (GO:0045161) | 1.91936226 |
98 | regulation of axon extension involved in axon guidance (GO:0048841) | 1.90527163 |
99 | regulation of synaptic vesicle exocytosis (GO:2000300) | 1.90112118 |
100 | negative regulation of Rho protein signal transduction (GO:0035024) | 1.89782194 |
101 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 1.89596819 |
102 | cerebellar Purkinje cell layer development (GO:0021680) | 1.89459095 |
103 | dermatan sulfate metabolic process (GO:0030205) | 1.89400542 |
104 | peripheral nervous system axon ensheathment (GO:0032292) | 1.89398175 |
105 | myelination in peripheral nervous system (GO:0022011) | 1.89398175 |
106 | phagocytosis, recognition (GO:0006910) | 1.89364712 |
107 | endothelial cell chemotaxis (GO:0035767) | 1.88512969 |
108 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 1.88126655 |
109 | neuron projection regeneration (GO:0031102) | 1.87990043 |
110 | positive regulation of glomerulus development (GO:0090193) | 1.87973130 |
111 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 1.87216732 |
112 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 1.85985450 |
113 | L-amino acid import (GO:0043092) | 1.85752349 |
114 | sodium ion export (GO:0071436) | 1.85690773 |
115 | neuron maturation (GO:0042551) | 1.84918596 |
116 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 1.84813147 |
117 | relaxation of cardiac muscle (GO:0055119) | 1.84590662 |
118 | regulation of ARF GTPase activity (GO:0032312) | 1.84102180 |
119 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 1.83542333 |
120 | regulation of respiratory gaseous exchange (GO:0043576) | 1.83319367 |
121 | negative regulation of catenin import into nucleus (GO:0035414) | 1.83054299 |
122 | mating behavior (GO:0007617) | 1.82843554 |
123 | regulation of synaptic vesicle transport (GO:1902803) | 1.82718714 |
124 | regulation of neuronal synaptic plasticity (GO:0048168) | 1.82552063 |
125 | regulation of beta-amyloid formation (GO:1902003) | 1.82437232 |
126 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 1.82343878 |
127 | positive regulation of Rap GTPase activity (GO:0032854) | 1.82159266 |
128 | regulation of synapse structural plasticity (GO:0051823) | 1.81725915 |
129 | urinary tract smooth muscle contraction (GO:0014848) | 1.81589943 |
130 | skeletal muscle cell differentiation (GO:0035914) | 1.81465445 |
131 | response to isoquinoline alkaloid (GO:0014072) | 1.81403773 |
132 | positive regulation of astrocyte differentiation (GO:0048711) | 1.81197158 |
133 | interleukin-1-mediated signaling pathway (GO:0070498) | 1.81087267 |
134 | axonal fasciculation (GO:0007413) | 1.80735647 |
135 | macrophage activation (GO:0042116) | 1.79871078 |
136 | dermatan sulfate biosynthetic process (GO:0030208) | 1.79856477 |
137 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 1.79743915 |
138 | response to laminar fluid shear stress (GO:0034616) | 1.79684839 |
139 | synaptic transmission, glutamatergic (GO:0035249) | 1.79430032 |
140 | polarized epithelial cell differentiation (GO:0030859) | 1.79214613 |
141 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 1.78420225 |
142 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 1.78149855 |
143 | negative regulation of neurotransmitter transport (GO:0051589) | 1.78036638 |
144 | hemidesmosome assembly (GO:0031581) | 1.77003216 |
145 | innervation (GO:0060384) | 1.76384354 |
146 | vesicle transport along microtubule (GO:0047496) | 1.75995430 |
147 | dendritic spine morphogenesis (GO:0060997) | 1.75983637 |
148 | regulation of NFAT protein import into nucleus (GO:0051532) | 1.75919327 |
149 | cellular response to fluid shear stress (GO:0071498) | 1.75710481 |
150 | * negative regulation of fatty acid transport (GO:2000192) | 1.75691009 |
151 | epithelial cell fate commitment (GO:0072148) | 1.75493878 |
152 | stress fiber assembly (GO:0043149) | 1.74739910 |
153 | regulation of histone deacetylation (GO:0031063) | 1.74209276 |
154 | alanine transport (GO:0032328) | 1.72545090 |
155 | exploration behavior (GO:0035640) | 1.71936985 |
156 | entrainment of circadian clock (GO:0009649) | 1.71233741 |
157 | dopaminergic neuron differentiation (GO:0071542) | 1.71140831 |
158 | enteric nervous system development (GO:0048484) | 1.71064931 |
159 | asymmetric protein localization (GO:0008105) | 1.70995924 |
160 | positive regulation of glial cell differentiation (GO:0045687) | 1.70699872 |
161 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 1.69535451 |
162 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 1.69413084 |
163 | photoperiodism (GO:0009648) | 1.69036270 |
164 | apical protein localization (GO:0045176) | 1.68856315 |
165 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 1.68408583 |
166 | camera-type eye morphogenesis (GO:0048593) | 1.68153718 |
167 | * positive regulation of glycogen biosynthetic process (GO:0045725) | 1.67967713 |
168 | ER overload response (GO:0006983) | 1.67877058 |
169 | glutamate secretion (GO:0014047) | 1.67114031 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.46945487 |
2 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.34850986 |
3 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.03869183 |
4 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.86310155 |
5 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.80537618 |
6 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.79705396 |
7 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.76300682 |
8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.74281760 |
9 | KDM2B_26808549_Chip-Seq_K562_Human | 1.73932879 |
10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.73120054 |
11 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.69018052 |
12 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.68693062 |
13 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.64598944 |
14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.64531716 |
15 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.62580227 |
16 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.60755203 |
17 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.60753785 |
18 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.58534462 |
19 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.56174098 |
20 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.55342377 |
21 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.55342377 |
22 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.51017675 |
23 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.49865854 |
24 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.48245424 |
25 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.47632701 |
26 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.47563543 |
27 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.46205544 |
28 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.43924621 |
29 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.43546104 |
30 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.42968875 |
31 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.41352863 |
32 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.40057982 |
33 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.38438190 |
34 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.37770737 |
35 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.36307229 |
36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.36234409 |
37 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.35662913 |
38 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.35245478 |
39 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.34626604 |
40 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.34251393 |
41 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.33420720 |
42 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.30694469 |
43 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.30421325 |
44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.29088204 |
45 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.28104573 |
46 | TP53_16413492_ChIP-PET_HCT116_Human | 1.27498371 |
47 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.26049949 |
48 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.25775390 |
49 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.24395467 |
50 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.23698776 |
51 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.23449814 |
52 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.22588188 |
53 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.21930470 |
54 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.21811589 |
55 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.21375116 |
56 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.20816396 |
57 | GATA1_19941826_ChIP-Seq_K562_Human | 1.20734321 |
58 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.18726923 |
59 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.18233031 |
60 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.18121733 |
61 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.17887407 |
62 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.17416111 |
63 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.16486237 |
64 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.14708172 |
65 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.14401267 |
66 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.13746235 |
67 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13633620 |
68 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.13029746 |
69 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.12973680 |
70 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.11068358 |
71 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.11033205 |
72 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.09822861 |
73 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.09699875 |
74 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.09530309 |
75 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.09284095 |
76 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.07885683 |
77 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.07840256 |
78 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.06128181 |
79 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.05955547 |
80 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.05878622 |
81 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.05456824 |
82 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.05165264 |
83 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.04536217 |
84 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.04069468 |
85 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03483439 |
86 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.02929834 |
87 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02099538 |
88 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.00938605 |
89 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 1.00671558 |
90 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.00375523 |
91 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.99482698 |
92 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.97990165 |
93 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97828173 |
94 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.97773210 |
95 | * RXR_22108803_ChIP-Seq_LS180_Human | 0.97520081 |
96 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.97289582 |
97 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.97214740 |
98 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97049904 |
99 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.96697584 |
100 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.95932356 |
101 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.95637624 |
102 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.95192639 |
103 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.95081824 |
104 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.94417406 |
105 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.94160333 |
106 | CJUN_26792858_Chip-Seq_BT549_Human | 0.94074145 |
107 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.93696717 |
108 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.93610711 |
109 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.92276040 |
110 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.92262578 |
111 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92246601 |
112 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.92134558 |
113 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.91978987 |
114 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91380118 |
115 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.91326546 |
116 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.91134195 |
117 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.90376218 |
118 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.89697225 |
119 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.89628000 |
120 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.88440185 |
121 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86345739 |
122 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.85644012 |
123 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.81827339 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002877_abnormal_melanocyte_morpholog | 3.58888861 |
2 | MP0008961_abnormal_basal_metabolism | 3.29426408 |
3 | MP0004510_myositis | 2.95703058 |
4 | MP0002254_reproductive_system_inflammat | 2.82783011 |
5 | MP0003300_gastrointestinal_ulcer | 2.73191151 |
6 | MP0009780_abnormal_chondrocyte_physiolo | 2.62818160 |
7 | MP0004858_abnormal_nervous_system | 2.51944220 |
8 | MP0003303_peritoneal_inflammation | 2.45956305 |
9 | MP0003045_fibrosis | 2.39935993 |
10 | MP0002909_abnormal_adrenal_gland | 2.35476063 |
11 | MP0005171_absent_coat_pigmentation | 2.32986690 |
12 | MP0005409_darkened_coat_color | 2.16150006 |
13 | MP0000003_abnormal_adipose_tissue | 2.14957367 |
14 | MP0001501_abnormal_sleep_pattern | 2.14323820 |
15 | MP0004859_abnormal_synaptic_plasticity | 2.07679571 |
16 | * MP0005076_abnormal_cell_differentiation | 1.96013211 |
17 | MP0001502_abnormal_circadian_rhythm | 1.84680113 |
18 | MP0005503_abnormal_tendon_morphology | 1.83107141 |
19 | MP0003705_abnormal_hypodermis_morpholog | 1.78784546 |
20 | MP0003453_abnormal_keratinocyte_physiol | 1.71665265 |
21 | MP0008438_abnormal_cutaneous_collagen | 1.69911933 |
22 | MP0003122_maternal_imprinting | 1.68981174 |
23 | MP0003879_abnormal_hair_cell | 1.68313391 |
24 | MP0003279_aneurysm | 1.58939401 |
25 | MP0001299_abnormal_eye_distance/ | 1.55821247 |
26 | MP0005375_adipose_tissue_phenotype | 1.55175242 |
27 | MP0000013_abnormal_adipose_tissue | 1.52398225 |
28 | MP0004270_analgesia | 1.47302664 |
29 | MP0005174_abnormal_tail_pigmentation | 1.46245467 |
30 | MP0010234_abnormal_vibrissa_follicle | 1.44085163 |
31 | MP0009278_abnormal_bone_marrow | 1.43508800 |
32 | MP0000569_abnormal_digit_pigmentation | 1.42686487 |
33 | MP0009379_abnormal_foot_pigmentation | 1.41787098 |
34 | MP0001970_abnormal_pain_threshold | 1.39184875 |
35 | MP0003566_abnormal_cell_adhesion | 1.38312869 |
36 | MP0005645_abnormal_hypothalamus_physiol | 1.36989505 |
37 | MP0001486_abnormal_startle_reflex | 1.35912412 |
38 | MP0002272_abnormal_nervous_system | 1.35611123 |
39 | MP0003075_altered_response_to | 1.34875738 |
40 | MP0003011_delayed_dark_adaptation | 1.33723563 |
41 | MP0003183_abnormal_peptide_metabolism | 1.33313558 |
42 | MP0010352_gastrointestinal_tract_polyps | 1.32427590 |
43 | MP0003635_abnormal_synaptic_transmissio | 1.28780495 |
44 | MP0002735_abnormal_chemical_nociception | 1.27630148 |
45 | MP0003283_abnormal_digestive_organ | 1.27033541 |
46 | MP0002896_abnormal_bone_mineralization | 1.26771847 |
47 | MP0004381_abnormal_hair_follicle | 1.24704118 |
48 | MP0001968_abnormal_touch/_nociception | 1.23259356 |
49 | MP0001177_atelectasis | 1.21787581 |
50 | MP0002653_abnormal_ependyma_morphology | 1.21506345 |
51 | MP0003172_abnormal_lysosome_physiology | 1.19984974 |
52 | MP0004264_abnormal_extraembryonic_tissu | 1.19748772 |
53 | MP0003787_abnormal_imprinting | 1.18965782 |
54 | MP0005623_abnormal_meninges_morphology | 1.18900167 |
55 | MP0002733_abnormal_thermal_nociception | 1.18607281 |
56 | MP0003690_abnormal_glial_cell | 1.15724635 |
57 | MP0002638_abnormal_pupillary_reflex | 1.15019532 |
58 | MP0008569_lethality_at_weaning | 1.14394531 |
59 | MP0005275_abnormal_skin_tensile | 1.13874296 |
60 | MP0004885_abnormal_endolymph | 1.12796899 |
61 | MP0002971_abnormal_brown_adipose | 1.11253606 |
62 | MP0004185_abnormal_adipocyte_glucose | 1.09613337 |
63 | MP0000762_abnormal_tongue_morphology | 1.08392770 |
64 | MP0002138_abnormal_hepatobiliary_system | 1.08052833 |
65 | MP0004130_abnormal_muscle_cell | 1.08010035 |
66 | MP0002168_other_aberrant_phenotype | 1.07377975 |
67 | MP0003880_abnormal_central_pattern | 1.06831373 |
68 | MP0003091_abnormal_cell_migration | 1.06766641 |
69 | MP0000733_abnormal_muscle_development | 1.04866330 |
70 | MP0001188_hyperpigmentation | 1.02968140 |
71 | MP0002060_abnormal_skin_morphology | 1.00370179 |
72 | MP0002998_abnormal_bone_remodeling | 1.00180015 |
73 | MP0002734_abnormal_mechanical_nocicepti | 0.99780377 |
74 | MP0005535_abnormal_body_temperature | 0.98655879 |
75 | * MP0005164_abnormal_response_to | 0.98590530 |
76 | MP0001346_abnormal_lacrimal_gland | 0.98589559 |
77 | MP0000678_abnormal_parathyroid_gland | 0.98208371 |
78 | MP0002133_abnormal_respiratory_system | 0.96381145 |
79 | MP0005388_respiratory_system_phenotype | 0.96381145 |
80 | MP0001340_abnormal_eyelid_morphology | 0.96024283 |
81 | MP0001958_emphysema | 0.95508740 |
82 | MP0005257_abnormal_intraocular_pressure | 0.95424929 |
83 | MP0001851_eye_inflammation | 0.94525008 |
84 | MP0002234_abnormal_pharynx_morphology | 0.93975161 |
85 | MP0000778_abnormal_nervous_system | 0.93809602 |
86 | MP0000920_abnormal_myelination | 0.93197151 |
87 | MP0002063_abnormal_learning/memory/cond | 0.93067061 |
88 | * MP0005595_abnormal_vascular_smooth | 0.92537297 |
89 | MP0003436_decreased_susceptibility_to | 0.91386144 |
90 | MP0000534_abnormal_ureter_morphology | 0.91156477 |
91 | MP0003828_pulmonary_edema | 0.90131318 |
92 | MP0005390_skeleton_phenotype | 0.90060941 |
93 | * MP0004883_abnormal_blood_vessel | 0.89656233 |
94 | MP0004742_abnormal_vestibular_system | 0.89320545 |
95 | MP0001440_abnormal_grooming_behavior | 0.87959840 |
96 | MP0004947_skin_inflammation | 0.87770882 |
97 | MP0002064_seizures | 0.87655671 |
98 | MP0003724_increased_susceptibility_to | 0.86912210 |
99 | MP0003329_amyloid_beta_deposits | 0.86891943 |
100 | * MP0001944_abnormal_pancreas_morphology | 0.86747159 |
101 | MP0009745_abnormal_behavioral_response | 0.86389095 |
102 | MP0005248_abnormal_Harderian_gland | 0.86303259 |
103 | MP0002822_catalepsy | 0.85519719 |
104 | MP0002295_abnormal_pulmonary_circulatio | 0.85449435 |
105 | MP0000955_abnormal_spinal_cord | 0.85440506 |
106 | MP0003634_abnormal_glial_cell | 0.85399628 |
107 | MP0002933_joint_inflammation | 0.84445603 |
108 | MP0000467_abnormal_esophagus_morphology | 0.84283817 |
109 | MP0005666_abnormal_adipose_tissue | 0.84093820 |
110 | MP0002009_preneoplasia | 0.83976253 |
111 | MP0002067_abnormal_sensory_capabilities | 0.82827950 |
112 | MP0004484_altered_response_of | 0.82084464 |
113 | MP0003942_abnormal_urinary_system | 0.80752266 |
114 | MP0008004_abnormal_stomach_pH | 0.80240949 |
115 | MP0004043_abnormal_pH_regulation | 0.79910038 |
116 | MP0005670_abnormal_white_adipose | 0.79471229 |
117 | MP0010678_abnormal_skin_adnexa | 0.79227782 |
118 | MP0000015_abnormal_ear_pigmentation | 0.79174866 |
119 | MP0001849_ear_inflammation | 0.78859887 |
120 | MP0009115_abnormal_fat_cell | 0.78161798 |
121 | MP0003115_abnormal_respiratory_system | 0.76955624 |
122 | MP0005423_abnormal_somatic_nervous | 0.76866598 |
123 | MP0003631_nervous_system_phenotype | 0.74052170 |
124 | MP0005508_abnormal_skeleton_morphology | 0.73008855 |
125 | * MP0002557_abnormal_social/conspecific_i | 0.72973488 |
126 | MP0002572_abnormal_emotion/affect_behav | 0.72931870 |
127 | MP0005387_immune_system_phenotype | 0.72750447 |
128 | MP0001790_abnormal_immune_system | 0.72750447 |
129 | MP0006138_congestive_heart_failure | 0.71738883 |
130 | MP0004924_abnormal_behavior | 0.71104455 |
131 | MP0005386_behavior/neurological_phenoty | 0.71104455 |
132 | MP0004811_abnormal_neuron_physiology | 0.71094117 |
133 | * MP0002693_abnormal_pancreas_physiology | 0.70974767 |
134 | MP0004272_abnormal_basement_membrane | 0.70512929 |
135 | * MP0002078_abnormal_glucose_homeostasis | 0.70371447 |
136 | MP0002928_abnormal_bile_duct | 0.69864948 |
137 | MP0009053_abnormal_anal_canal | 0.69263552 |
138 | MP0001348_abnormal_lacrimal_gland | 0.69154081 |
139 | MP0001881_abnormal_mammary_gland | 0.68992962 |
140 | MP0001270_distended_abdomen | 0.68900888 |
141 | * MP0005334_abnormal_fat_pad | 0.68792538 |
142 | MP0002108_abnormal_muscle_morphology | 0.67635646 |
143 | MP0003633_abnormal_nervous_system | 0.66653088 |
144 | MP0003632_abnormal_nervous_system | 0.65494436 |
145 | MP0001533_abnormal_skeleton_physiology | 0.64730361 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.33011686 |
2 | Macroorchidism (HP:0000053) | 3.21148251 |
3 | Persistence of primary teeth (HP:0006335) | 2.96778144 |
4 | Broad face (HP:0000283) | 2.96759511 |
5 | Turricephaly (HP:0000262) | 2.87777989 |
6 | Amyloidosis (HP:0011034) | 2.84385369 |
7 | Sleep apnea (HP:0010535) | 2.69765419 |
8 | Shallow orbits (HP:0000586) | 2.64076906 |
9 | Abnormality of the nasal septum (HP:0000419) | 2.60142913 |
10 | Hypercortisolism (HP:0001578) | 2.57597522 |
11 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.48382162 |
12 | Aplasia of the phalanges of the hand (HP:0009802) | 2.48382162 |
13 | Aplasia involving bones of the extremities (HP:0009825) | 2.48382162 |
14 | Bronchomalacia (HP:0002780) | 2.46917694 |
15 | Abnormality of binocular vision (HP:0011514) | 2.37782695 |
16 | Diplopia (HP:0000651) | 2.37782695 |
17 | Cerebral aneurysm (HP:0004944) | 2.35323853 |
18 | Abnormality of incisor morphology (HP:0011063) | 2.25360557 |
19 | Febrile seizures (HP:0002373) | 2.24064130 |
20 | Lower limb amyotrophy (HP:0007210) | 2.23372905 |
21 | Increased density of long bones (HP:0006392) | 2.18659938 |
22 | Mild short stature (HP:0003502) | 2.17374929 |
23 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.16130864 |
24 | Action tremor (HP:0002345) | 2.15912831 |
25 | Supranuclear gaze palsy (HP:0000605) | 2.14334941 |
26 | Cerebral inclusion bodies (HP:0100314) | 2.14069817 |
27 | Focal motor seizures (HP:0011153) | 2.10368609 |
28 | Choroideremia (HP:0001139) | 2.07611830 |
29 | Arthropathy (HP:0003040) | 2.07243085 |
30 | Neurofibrillary tangles (HP:0002185) | 2.05253225 |
31 | Hypoventilation (HP:0002791) | 2.05118490 |
32 | Absent frontal sinuses (HP:0002688) | 2.02607260 |
33 | Hemiplegia (HP:0002301) | 2.02432047 |
34 | Annular pancreas (HP:0001734) | 2.01843090 |
35 | Progressive cerebellar ataxia (HP:0002073) | 2.01373964 |
36 | Lip pit (HP:0100267) | 2.01211946 |
37 | Protrusio acetabuli (HP:0003179) | 2.00409267 |
38 | Neonatal short-limb short stature (HP:0008921) | 1.99373593 |
39 | Genu recurvatum (HP:0002816) | 1.98984074 |
40 | Myocardial infarction (HP:0001658) | 1.98174755 |
41 | Agitation (HP:0000713) | 1.98171871 |
42 | Hypoplasia of the iris (HP:0007676) | 1.97925689 |
43 | Aqueductal stenosis (HP:0002410) | 1.93343457 |
44 | Wormian bones (HP:0002645) | 1.92056318 |
45 | Vertebral arch anomaly (HP:0008438) | 1.91442419 |
46 | Genetic anticipation (HP:0003743) | 1.91159115 |
47 | Myokymia (HP:0002411) | 1.90464394 |
48 | Broad metatarsal (HP:0001783) | 1.90009880 |
49 | Mitral regurgitation (HP:0001653) | 1.89648435 |
50 | Disproportionate tall stature (HP:0001519) | 1.87668490 |
51 | Hypoplastic labia majora (HP:0000059) | 1.87516207 |
52 | Epileptic encephalopathy (HP:0200134) | 1.86875811 |
53 | Mitral valve prolapse (HP:0001634) | 1.83970948 |
54 | Striae distensae (HP:0001065) | 1.83965591 |
55 | Distal lower limb amyotrophy (HP:0008944) | 1.83695245 |
56 | Peritonitis (HP:0002586) | 1.83538024 |
57 | Hyperglycemia (HP:0003074) | 1.82570051 |
58 | Blue irides (HP:0000635) | 1.82485037 |
59 | Atonic seizures (HP:0010819) | 1.82480415 |
60 | Megalencephaly (HP:0001355) | 1.82388452 |
61 | Facial shape deformation (HP:0011334) | 1.82024144 |
62 | Potter facies (HP:0002009) | 1.82024144 |
63 | Interstitial pulmonary disease (HP:0006530) | 1.81841664 |
64 | Enlarged penis (HP:0000040) | 1.81538300 |
65 | Hyporeflexia of lower limbs (HP:0002600) | 1.81236959 |
66 | Abnormality of the 2nd finger (HP:0004100) | 1.80772663 |
67 | Hyperventilation (HP:0002883) | 1.80661030 |
68 | Obstructive sleep apnea (HP:0002870) | 1.80266399 |
69 | Abnormality of the parietal bone (HP:0002696) | 1.79914852 |
70 | Failure to thrive in infancy (HP:0001531) | 1.77512189 |
71 | Stomach cancer (HP:0012126) | 1.76582435 |
72 | Increased CSF protein (HP:0002922) | 1.76397445 |
73 | Vitreoretinal degeneration (HP:0000655) | 1.75322632 |
74 | Arterial tortuosity (HP:0005116) | 1.74428169 |
75 | Thin bony cortex (HP:0002753) | 1.74277704 |
76 | Vascular tortuosity (HP:0004948) | 1.73624263 |
77 | Round face (HP:0000311) | 1.72106839 |
78 | Postural instability (HP:0002172) | 1.71714891 |
79 | Alacrima (HP:0000522) | 1.71121813 |
80 | Buphthalmos (HP:0000557) | 1.70158817 |
81 | Episodic fever (HP:0001954) | 1.70121987 |
82 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.69651788 |
83 | Thickened helices (HP:0000391) | 1.69528874 |
84 | Hyperextensible skin (HP:0000974) | 1.68968452 |
85 | Lower limb asymmetry (HP:0100559) | 1.68931536 |
86 | Hyperparathyroidism (HP:0000843) | 1.68831169 |
87 | Narrow palate (HP:0000189) | 1.68757915 |
88 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.68664847 |
89 | Spondylolisthesis (HP:0003302) | 1.68492403 |
90 | Global brain atrophy (HP:0002283) | 1.68375715 |
91 | Coronal craniosynostosis (HP:0004440) | 1.68132278 |
92 | Wide anterior fontanel (HP:0000260) | 1.68072042 |
93 | Aneurysm (HP:0002617) | 1.67995302 |
94 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.67661196 |
95 | Aortic regurgitation (HP:0001659) | 1.67504345 |
96 | Supernumerary ribs (HP:0005815) | 1.67456955 |
97 | Hypoplastic ischia (HP:0003175) | 1.67346450 |
98 | Tracheomalacia (HP:0002779) | 1.66924610 |
99 | Peripheral hypomyelination (HP:0007182) | 1.66714084 |
100 | Prolonged QT interval (HP:0001657) | 1.66530081 |
101 | Abnormal eating behavior (HP:0100738) | 1.66230512 |
102 | Papilledema (HP:0001085) | 1.64781677 |
103 | Ocular albinism (HP:0001107) | 1.64495949 |
104 | Onion bulb formation (HP:0003383) | 1.64345625 |
105 | Cervical subluxation (HP:0003308) | 1.64190029 |
106 | Fragile skin (HP:0001030) | 1.63664423 |
107 | Abnormality of the ischium (HP:0003174) | 1.63214143 |
108 | Insomnia (HP:0100785) | 1.62507069 |
109 | Hypoplasia of the maxilla (HP:0000327) | 1.62166749 |
110 | Muscle fiber splitting (HP:0003555) | 1.62022261 |
111 | Long palpebral fissure (HP:0000637) | 1.61881809 |
112 | Truncal ataxia (HP:0002078) | 1.61847057 |
113 | Laryngomalacia (HP:0001601) | 1.61809598 |
114 | Labial hypoplasia (HP:0000066) | 1.61392327 |
115 | Milia (HP:0001056) | 1.61343708 |
116 | Abnormality of secondary sexual hair (HP:0009888) | 1.60823055 |
117 | Abnormality of the axillary hair (HP:0100134) | 1.60823055 |
118 | Abnormality of the labia majora (HP:0012881) | 1.60297442 |
119 | Arnold-Chiari malformation (HP:0002308) | 1.59697025 |
120 | Oligodontia (HP:0000677) | 1.59507578 |
121 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.58969616 |
122 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.58969616 |
123 | Supernumerary nipples (HP:0002558) | 1.57418113 |
124 | Tibial bowing (HP:0002982) | 1.55817348 |
125 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.55479289 |
126 | Dislocated radial head (HP:0003083) | 1.55443703 |
127 | Urethral obstruction (HP:0000796) | 1.54174541 |
128 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.54133973 |
129 | Narrow nasal bridge (HP:0000446) | 1.52835681 |
130 | Eczematoid dermatitis (HP:0000976) | 1.51989168 |
131 | Achilles tendon contracture (HP:0001771) | 1.50120481 |
132 | Congenital glaucoma (HP:0001087) | 1.49707970 |
133 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.49544144 |
134 | Ulnar bowing (HP:0003031) | 1.49530356 |
135 | Anteriorly placed anus (HP:0001545) | 1.49495360 |
136 | Focal seizures (HP:0007359) | 1.48991253 |
137 | Acanthosis nigricans (HP:0000956) | 1.48590279 |
138 | Abnormality of the fingertips (HP:0001211) | 1.47490621 |
139 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.47094919 |
140 | Abnormality of the corticospinal tract (HP:0002492) | 1.46541764 |
141 | Ankyloglossia (HP:0010296) | 1.46321953 |
142 | Scapular winging (HP:0003691) | 1.45131065 |
143 | Pheochromocytoma (HP:0002666) | 1.44951082 |
144 | Growth hormone excess (HP:0000845) | 1.44578450 |
145 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.43988246 |
146 | Menstrual irregularities (HP:0000858) | 1.43129390 |
147 | Hepatoblastoma (HP:0002884) | 1.43009332 |
148 | Mitral stenosis (HP:0001718) | 1.42744151 |
149 | Atrophic scars (HP:0001075) | 1.42412014 |
150 | Abnormality of the gastric mucosa (HP:0004295) | 1.42272754 |
151 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.42179354 |
152 | Ulnar claw (HP:0001178) | 1.42150896 |
153 | Broad thumb (HP:0011304) | 1.41998405 |
154 | Hyperkalemia (HP:0002153) | 1.41865324 |
155 | Overgrowth (HP:0001548) | 1.41700868 |
156 | Hypoplasia of dental enamel (HP:0006297) | 1.40867405 |
157 | Distal upper limb amyotrophy (HP:0007149) | 1.40221986 |
158 | Upper limb amyotrophy (HP:0009129) | 1.40221986 |
159 | Aortic aneurysm (HP:0004942) | 1.39536631 |
160 | Difficulty running (HP:0009046) | 1.39513971 |
161 | Hyperacusis (HP:0010780) | 1.38165886 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHB1 | 2.90972141 |
2 | MAPK15 | 2.84390936 |
3 | PRPF4B | 2.70544241 |
4 | EPHA3 | 2.59890169 |
5 | TRIB3 | 2.41530348 |
6 | MAP3K2 | 2.37327794 |
7 | SIK1 | 2.12110330 |
8 | MAP3K9 | 2.02751064 |
9 | IRAK2 | 1.88094996 |
10 | RIPK1 | 1.78091145 |
11 | HIPK2 | 1.77386777 |
12 | PRKD3 | 1.71194264 |
13 | MAP3K10 | 1.66663444 |
14 | BLK | 1.64506292 |
15 | NTRK1 | 1.63893187 |
16 | CDK12 | 1.60973264 |
17 | FGFR2 | 1.60712908 |
18 | CAMK1G | 1.58469437 |
19 | AKT3 | 1.57622357 |
20 | PTK2 | 1.53665858 |
21 | TNK2 | 1.48640526 |
22 | PTK6 | 1.44547263 |
23 | MAPK12 | 1.43357923 |
24 | MARK1 | 1.39744159 |
25 | RET | 1.37036315 |
26 | ERN1 | 1.36986707 |
27 | DMPK | 1.35393971 |
28 | LATS2 | 1.34288675 |
29 | NTRK3 | 1.32983823 |
30 | LATS1 | 1.32158222 |
31 | FGFR4 | 1.31772591 |
32 | MAP2K3 | 1.30977621 |
33 | PDGFRA | 1.28848582 |
34 | FGFR3 | 1.27108867 |
35 | CHUK | 1.27021854 |
36 | ALK | 1.26409983 |
37 | DAPK2 | 1.25552990 |
38 | TAOK3 | 1.21126180 |
39 | CAMK1D | 1.19776694 |
40 | BMX | 1.18019857 |
41 | INSRR | 1.16812935 |
42 | MAPKAPK5 | 1.16244179 |
43 | JAK1 | 1.14192726 |
44 | MAP3K1 | 1.11570444 |
45 | MAP3K6 | 1.06564183 |
46 | SGK3 | 1.06506990 |
47 | CAMK1 | 1.05816704 |
48 | LMTK2 | 1.05359039 |
49 | TYRO3 | 1.03152816 |
50 | MAP2K2 | 1.00686585 |
51 | FER | 0.98696474 |
52 | PRKCH | 0.98087936 |
53 | STK38 | 0.95862916 |
54 | WNK1 | 0.95620893 |
55 | GRK6 | 0.95237409 |
56 | TRPM7 | 0.93649951 |
57 | MOS | 0.90987696 |
58 | CASK | 0.90447605 |
59 | RPS6KA2 | 0.88598101 |
60 | MAP3K14 | 0.88088274 |
61 | MAP3K3 | 0.87951006 |
62 | KSR2 | 0.86520499 |
63 | PKN1 | 0.83909729 |
64 | TTN | 0.83724942 |
65 | SIK2 | 0.83077239 |
66 | * MTOR | 0.82389273 |
67 | FRK | 0.81615955 |
68 | MAP3K13 | 0.81005356 |
69 | SGK494 | 0.80800059 |
70 | SGK223 | 0.80800059 |
71 | CDC42BPA | 0.80698420 |
72 | UHMK1 | 0.80239581 |
73 | STK11 | 0.79269140 |
74 | IRAK4 | 0.78632575 |
75 | PDK2 | 0.77369221 |
76 | PNCK | 0.77191836 |
77 | * PDGFRB | 0.76460204 |
78 | PAK6 | 0.74004945 |
79 | PDK1 | 0.73865168 |
80 | ICK | 0.73477006 |
81 | IKBKB | 0.73391706 |
82 | MAP3K7 | 0.73233869 |
83 | MARK2 | 0.72501275 |
84 | EPHA4 | 0.70813893 |
85 | PAK3 | 0.69548975 |
86 | * GSK3A | 0.67236834 |
87 | MET | 0.67187435 |
88 | PRKD1 | 0.66819460 |
89 | NTRK2 | 0.65563402 |
90 | ITK | 0.65482277 |
91 | DDR2 | 0.63038864 |
92 | MAP2K4 | 0.61879453 |
93 | CDK5 | 0.60811971 |
94 | PRKAA2 | 0.60523040 |
95 | CDK9 | 0.60223343 |
96 | JAK2 | 0.60095002 |
97 | YES1 | 0.60064486 |
98 | ZAP70 | 0.59874129 |
99 | RIPK4 | 0.59713534 |
100 | DYRK1A | 0.59279344 |
101 | SGK2 | 0.59070435 |
102 | NLK | 0.58921008 |
103 | TAOK1 | 0.58643273 |
104 | PDPK1 | 0.57792410 |
105 | DYRK1B | 0.57197372 |
106 | IRAK1 | 0.56927283 |
107 | MAP3K4 | 0.55771025 |
108 | CDK6 | 0.55014807 |
109 | MAPK7 | 0.54708196 |
110 | NEK6 | 0.54181000 |
111 | MAPK4 | 0.54027385 |
112 | PRKD2 | 0.53845220 |
113 | RPS6KL1 | 0.53718153 |
114 | RPS6KC1 | 0.53718153 |
115 | EPHB2 | 0.53009034 |
116 | SGK1 | 0.52954918 |
117 | RPS6KA6 | 0.51821325 |
118 | PAK2 | 0.51587596 |
119 | CAMK4 | 0.51344614 |
120 | RPS6KA1 | 0.51277197 |
121 | IRAK3 | 0.51231815 |
122 | PTK2B | 0.50347728 |
123 | HCK | 0.50250685 |
124 | WNK4 | 0.49554642 |
125 | CAMK2B | 0.48135288 |
126 | CAMKK1 | 0.46929128 |
127 | FES | 0.46874229 |
128 | EEF2K | 0.46133854 |
129 | FGFR1 | 0.43000691 |
130 | MAPK10 | 0.42886302 |
131 | GRK5 | 0.41150772 |
132 | MAP2K1 | 0.40804430 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.77450237 |
2 | * Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.61577133 |
3 | Nicotine addiction_Homo sapiens_hsa05033 | 1.61240552 |
4 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.59313966 |
5 | Cocaine addiction_Homo sapiens_hsa05030 | 1.50075411 |
6 | Insulin secretion_Homo sapiens_hsa04911 | 1.45338879 |
7 | * Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.45064764 |
8 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.44274922 |
9 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.34454168 |
10 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.33714050 |
11 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.24203025 |
12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.22483516 |
13 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.20304905 |
14 | Circadian rhythm_Homo sapiens_hsa04710 | 1.19455185 |
15 | Renin secretion_Homo sapiens_hsa04924 | 1.18507541 |
16 | Circadian entrainment_Homo sapiens_hsa04713 | 1.17952558 |
17 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.17569311 |
18 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.15256341 |
19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.14013947 |
20 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.13348041 |
21 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.12920132 |
22 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.11123005 |
23 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.10034292 |
24 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.08494562 |
25 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.08113702 |
26 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.07305695 |
27 | Glioma_Homo sapiens_hsa05214 | 1.06028575 |
28 | Long-term depression_Homo sapiens_hsa04730 | 1.04998508 |
29 | * Insulin resistance_Homo sapiens_hsa04931 | 1.03493027 |
30 | Salivary secretion_Homo sapiens_hsa04970 | 1.02488271 |
31 | Long-term potentiation_Homo sapiens_hsa04720 | 1.01886003 |
32 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.99699521 |
33 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.99637283 |
34 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.98120903 |
35 | Melanogenesis_Homo sapiens_hsa04916 | 0.98044447 |
36 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.97619004 |
37 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.95206159 |
38 | Axon guidance_Homo sapiens_hsa04360 | 0.94884694 |
39 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.94147058 |
40 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.93891899 |
41 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.93291861 |
42 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.91171826 |
43 | GABAergic synapse_Homo sapiens_hsa04727 | 0.90758074 |
44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.89235879 |
45 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.88681629 |
46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.88504829 |
47 | Endometrial cancer_Homo sapiens_hsa05213 | 0.88476175 |
48 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.87632011 |
49 | Prion diseases_Homo sapiens_hsa05020 | 0.87252473 |
50 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.86781628 |
51 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.86164429 |
52 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.85857782 |
53 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.85723369 |
54 | Bladder cancer_Homo sapiens_hsa05219 | 0.85442228 |
55 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84651311 |
56 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.83855499 |
57 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.83840314 |
58 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.82160611 |
59 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.80562984 |
60 | Focal adhesion_Homo sapiens_hsa04510 | 0.79961219 |
61 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.79487854 |
62 | Morphine addiction_Homo sapiens_hsa05032 | 0.78765327 |
63 | Amoebiasis_Homo sapiens_hsa05146 | 0.78190861 |
64 | Gap junction_Homo sapiens_hsa04540 | 0.77833854 |
65 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.77515339 |
66 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.77381102 |
67 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.77321998 |
68 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.77099925 |
69 | Adherens junction_Homo sapiens_hsa04520 | 0.76754423 |
70 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.76437548 |
71 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.74064253 |
72 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.74054699 |
73 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.73359863 |
74 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.73157533 |
75 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.72146737 |
76 | * Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.72067763 |
77 | Olfactory transduction_Homo sapiens_hsa04740 | 0.71703500 |
78 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.70797225 |
79 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.70156576 |
80 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69670907 |
81 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.69431722 |
82 | Prostate cancer_Homo sapiens_hsa05215 | 0.69104177 |
83 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.68167814 |
84 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.67023396 |
85 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.66904368 |
86 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.66770724 |
87 | * Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.66346148 |
88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.66001440 |
89 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.65826513 |
90 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.65777826 |
91 | Bile secretion_Homo sapiens_hsa04976 | 0.64280667 |
92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63979869 |
93 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.63876138 |
94 | Platelet activation_Homo sapiens_hsa04611 | 0.63355766 |
95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.63125609 |
96 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.62875591 |
97 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.62705842 |
98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.62117793 |
99 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.62102656 |
100 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.61773290 |
101 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.61064946 |
102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.60952670 |
103 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.60634545 |
104 | Melanoma_Homo sapiens_hsa05218 | 0.60431110 |
105 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.60282537 |
106 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.59720201 |
107 | Endocytosis_Homo sapiens_hsa04144 | 0.59540279 |
108 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.59279079 |
109 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.59247917 |
110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58905082 |
111 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.58793874 |
112 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.58642843 |
113 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.58137689 |
114 | Lysine degradation_Homo sapiens_hsa00310 | 0.57459786 |
115 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57243282 |
116 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56427885 |
117 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53879788 |
118 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.52946639 |
119 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.51242694 |